Please assess the completion status of the following clinical trial:

Trial Title: Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 65 or older~* Diagnosis of a malignancy requiring chemotherapy as part of intent to cure oncologic therapy or diagnosis of prostate cancer requiring 6 months or less of androgen deprivation therapy as part of oncologic treatment.~* A planned oncologic regimen of at least 3 months but not more than 9 months excluding surgery. This will include most solid tumors and lymphoma.~* Ability to understand and the willingness to sign a written informed consent document.~Exclusion Criteria:~* Prior treatment for malignancy other than basal or squamous cell skin cancer~* Evidence of metastatic disease~* Individuals with acute and chronic leukemias and individuals receiving anti-estrogen therapy only as their primary oncologic treatment.~* Dementia, psychotic condition or other central nervous system impairment limiting compliance~* Medical conditions that limit ability to walk at least 4 meters.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Individuals age 65 or older (Type: None): Individuals age 65 or older receiving chemotherapy for cancer or short term androgen deprivation therapy for individuals 65 or older with prostate cancer.

Based on this trial design, predict the completion outcome and termination type (if applicable).